Maverick Capital, Ltd. 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 8,261,242 5.400% | -186,562 (-2.21%) | Filing |
| 2024-02-14 5:02 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 8,447,804 6.900% | 1,350,140 (+19.02%) | Filing |
| 2023-02-14 11:53 am Purchase | 2022-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 7,097,664 8.200% | 1,504,275 (+26.89%) | Filing |
| 2022-02-14 3:07 pm Purchase | 2021-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 5,593,389 9.500% | 5,593,389 (New Position) | Filing |